Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v2.4.1.9
Segment Disclosures
 3 Months Ended
Mar. 31, 2015
Segment Disclosures [Abstract]  
Segment Disclosures

15. Segment Disclosures

 

The Company has two reportable segments, Engineering Services and Medical. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.

 

The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

 

Segment reporting information is as follows:

 

Engineering   Medical           
Services   Devices     Total  
Three months ended March 31, 2015                  
Revenue $ 704     $ 985     $ 1,689  
Cost of revenue     488       798       1,286  
Gross profit   $ 216     $ 187     $ 403  
                         
Three months ended March 31, 2014                        
Revenue   $ 535     $ 527     $ 1,062  
Cost of revenue     252       330       582  
Gross profit   $ 283     $ 197     $ 480  

 

Geographic information for revenue based on location of customer is as follows:

 

Three Months Ended March 31,  
2015     2014  
North America $ 1,271     $ 890  
All Other   418       172  
    $ 1,689     $ 1,062